National Guideline Clearinghouse | Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Guideline Title
National Institute for Health and Clinical Excellence (NICE)
Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 Oct. 47 p. (Technology appraisal guidance; no. 205).

Guideline Status
This is the current release of the guideline.

full-text:
National Guideline Clearinghouse | Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.